Ignite Creation Date:
2024-05-06 @ 7:24 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06008106
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2023-08-08
Brief Title:
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
Sponsor:
Shanghai Kechow Pharma Inc
Organization:
Shanghai Kechow Pharma Inc
Organization Data
Organization:
Shanghai Kechow Pharma Inc
Class:
INDUSTRY
Study ID:
HL-085-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Kechow Pharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None